Boston to snap up atrial fibrillation collaborator for $18m
This article was originally published in Clinica
Executive Summary
Boston Scientific is set to strengthen its position in the atrial fibrillation (AF) market with the purchase of CryoCor, a developer of disposable catheter systems for cardiac cryoablation procedures.